Maternal Sirolimus Treatment Reverses Cardiac Rhabdomyoma‐Induced Hydrops Fetalis in a Twin Gestation With Tuberous Sclerosis Complex
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64175 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von David M Ritter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Hauptthemen laut MEDLINE: Rhabdomyoma, Tuberous Sclerosis, Hydrops Fetalis, Sirolimus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Congressionally Directed Medical Research Programs.
Abstract (Originalsprache)
Cardiac rhabdomyomas are often the presenting sign of tuberous sclerosis complex (TSC). Prior reports have shown that maternal sirolimus treatment can reduce rhabdomyomas. We used maternal sirolimus to reverse hydrops fetalis due to a massive cardiac rhabdomyoma in a twin gestation. This expands the possibilities of prenatal medical treatment in TSC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
- University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
ORCID-Profile: David M Ritter, Nkiru Ezeakudo, Darcy A Krueger, David N Franz
Förderung
- Congressionally Directed Medical Research Programs
Zitieren
APA
Ritter, D. M., Schneider, K., Ezeakudo, N., Krueger, D. A., Mizuno, T., Knilans, T. K., & Franz, D. N. (2025). Maternal Sirolimus Treatment Reverses Cardiac Rhabdomyoma‐Induced Hydrops Fetalis in a Twin Gestation With Tuberous Sclerosis Complex. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64175
Vancouver
Ritter DM, Schneider K, Ezeakudo N, Krueger DA, Mizuno T, Knilans TK, et al. Maternal Sirolimus Treatment Reverses Cardiac Rhabdomyoma‐Induced Hydrops Fetalis in a Twin Gestation With Tuberous Sclerosis Complex. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64175
BibTeX
@article{Ritter2025,
author = {Ritter, David M and Schneider, Kristin and Ezeakudo, Nkiru and Krueger, Darcy A and Mizuno, Tomoyuki and Knilans, Timothy K and Franz, David N},
title = {Maternal Sirolimus Treatment Reverses Cardiac Rhabdomyoma‐Induced Hydrops Fetalis in a Twin Gestation With Tuberous Sclerosis Complex},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64175}
}
EUVIMED